Wintech Nano
688757
CHANGFU CO.,LTD
871396
DIER CHEMICAL
831304
4
CHENGUANG MEDICAL
430300
5
TLC
873576
US Stock MarketDetailed Quotes
NNVC Nanoviricides
- 1.290
- -0.040-3.01%
Trading Mar 25 15:44 ET
20.18MMarket Cap-1.82P/E (TTM)
1.328High1.260Low39.01KVolume1.300Open1.330Pre Close50.55KTurnover0.26%Turnover RatioLossP/E (Static)15.64MShares3.59052wk High1.94P/B19.45MFloat Cap1.03052wk Low--Dividend TTM15.07MShs Float262.500Historical High--Div YieldTTM5.08%Amplitude1.000Historical Low1.295Avg Price1Lot Size
Nanoviricides Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -5.75%2.06M | 55.93%3.17M | -4.78%8.52M | -34.95%2.39M | 5.39%1.91M | 19.13%2.18M | 25.22%2.03M | 10.23%8.94M | 105.07%3.68M | 1.28%1.81M |
| Selling and administrative expenses | 47.77%902.7K | 118.57%1.23M | 20.69%3.08M | 58.40%1.21M | 12.87%693.74K | -7.90%610.88K | 10.83%564.93K | 9.55%2.55M | 22.89%763.42K | 15.36%614.65K |
| -General and administrative expense | 47.77%902.7K | 118.57%1.23M | 20.69%3.08M | 58.40%1.21M | 12.87%693.74K | -7.90%610.88K | 10.83%564.93K | 9.55%2.55M | 22.89%763.42K | 15.36%614.65K |
| Research and development costs | -26.53%1.16M | 31.80%1.93M | -14.94%5.44M | -59.42%1.18M | 1.55%1.21M | 34.44%1.57M | 31.82%1.47M | 10.50%6.39M | 148.64%2.91M | -4.70%1.2M |
| Operating profit | 5.75%-2.06M | -55.93%-3.17M | 4.78%-8.52M | 34.95%-2.39M | -5.39%-1.91M | -19.13%-2.18M | -25.22%-2.03M | -10.23%-8.94M | -105.07%-3.68M | -1.28%-1.81M |
| Net non-operating interest income expense | -54.80%31.56K | -34.72%41.02K | -37.46%221.97K | -66.75%35.37K | -50.04%53.93K | -21.43%69.82K | 21.51%62.85K | 5,168.63%354.9K | 732.00%106.38K | 2,353.85%107.94K |
| Non-operating interest income | -61.86%31.71K | -58.70%41.02K | -23.62%271.77K | -66.75%35.37K | -50.04%53.93K | -6.54%83.13K | 88.99%99.34K | 2,900.53%355.83K | 797.04%106.38K | --107.94K |
| Non-operating interest expense | -98.88%149 | --0 | 5,210.02%49.81K | --0 | --0 | 14,064.89%13.32K | 4,223.82%36.49K | -81.69%938 | --0 | --0 |
| Other net income (expense) | ||||||||||
| Income before tax | 4.13%-2.03M | -58.82%-3.13M | 3.43%-8.29M | 34.01%-2.36M | -8.91%-1.85M | -21.19%-2.11M | -25.35%-1.97M | -5.94%-8.59M | -100.56%-3.57M | 5.01%-1.7M |
| Income tax | ||||||||||
| Net income | 4.13%-2.03M | -58.82%-3.13M | 3.43%-8.29M | 34.01%-2.36M | -8.91%-1.85M | -21.19%-2.11M | -25.35%-1.97M | -5.94%-8.59M | -100.56%-3.57M | 5.01%-1.7M |
| Net income continuous Operations | 4.13%-2.03M | -58.82%-3.13M | 3.43%-8.29M | 34.01%-2.36M | -8.91%-1.85M | -21.19%-2.11M | -25.35%-1.97M | -5.94%-8.59M | -100.56%-3.57M | 5.01%-1.7M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 4.13%-2.03M | -58.82%-3.13M | 3.43%-8.29M | 34.01%-2.36M | -8.91%-1.85M | -21.19%-2.11M | -25.35%-1.97M | -5.94%-8.59M | -100.56%-3.57M | 5.01%-1.7M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 4.13%-2.03M | -58.82%-3.13M | 3.43%-8.29M | 34.01%-2.36M | -8.91%-1.85M | -21.19%-2.11M | -25.35%-1.97M | -5.94%-8.59M | -100.56%-3.57M | 5.01%-1.7M |
| Basic earnings per share | 22.22%-0.14 | -35.29%-0.23 | 5.41%-0.7 | 38.71%-0.19 | -6.67%-0.16 | -20.00%-0.18 | -21.43%-0.17 | -5.71%-0.74 | -106.67%-0.31 | 6.25%-0.15 |
| Diluted earnings per share | 22.22%-0.14 | -35.29%-0.23 | 5.41%-0.7 | 38.71%-0.19 | -6.67%-0.16 | -20.00%-0.18 | -21.43%-0.17 | -5.71%-0.74 | -106.67%-0.31 | 6.25%-0.15 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025